ACTRN12621001127897尚未招募2 期
Ketamine treatment for psychogenic non-epileptic seizures
Department of Psychological medicine, Otago University0 个研究点目标入组 10 人开始时间: 2021年8月23日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Capable of understanding and signing an informed consent
- •2.Aged >18 years on the day of consent.
- •3.Have an established diagnosis of PNES by a neurologist and have failed to benefit from psychoeducation using the explanation suggested
排除标准
- •To be included in the study, participants must meet none of the following exclusion criteria:
- •1.Female participants who are or intend to become pregnant, or are lactating
- •2.Participants who, in the opinion of the investigator, do not understand the information and procedures of the study, or would not be compliant with them (in particular the study restrictions and risks involved).
- •3.Any participant for whom the investigator believes, for any reason, that participation would not be an acceptable risk.
- •4.Starting new antidepressants, anxiolytics or psychotherapy within 4 weeks of enrolment. Use of antidepressants, anxiolytics at stable doses > 4 weeks prior or psychotherapy is acceptable.
- •5.Participants with severe acute or chronic medical illnesses.
- •6.Participants with comorbid schizophrenia, bipolar disorder and severe personality disorders, comorbid depression and anxiety is acceptable
- •7.Participants with current drug or alcohol abuse problems
- •8.Participants with current active suicidal ideation
- •9.Participants with any current controlled or uncontrolled epileptic seizures as diagnosed by a neurologist
研究者
相似试验
进行中（未招募）
不适用
Ketamine as an alternative to electrocolvulsive therapy for treatment of major depressive disorderMajor depression disorderMedDRA version: 18.0Level: PTClassification code 10019063Term: HallucinationSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 18.0Level: PTClassification code 10013036Term: DiplopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 18.0Level: LLTClassification code 10061243Term: Post procedural nauseaSystem Organ Class: 100000004863MedDRA version: 18.0Level: PTClassification code 10047343Term: Vertigo CNS originSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.0Level: LLTClassification code 10015533Term: EuphoriaSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-001520-37-SESkåne University Hospital, Malmö
进行中（未招募）
1 期
Ketamine interleaved with electroconvulsive therapy for depression, a pragmatic randomised controlled pilot trial (KITE-Dep)DepressionEUCTR2018-003421-28-IESt Patrick's Mental Health Services24
招募中
1 期
Ketamine and Internalizing DisordersDepressionObsessive-Compulsive DisorderPost-Traumatic Stress DisorderACTRN12619000311156niversity of Otago48
已完成
不适用
Ketamine-ECT StudyISRCTN14689382Manchester Mental Health & Social Care Trust (UK)160
招募中
不适用
Evaluation of the use of ketamine medication in the treatment of depressed or bipolar personsmajor depressive disorder, bipolar disorder, suicide riskF32.9F31.9RBR-472gf3Hospital São José